Novel Agent Anchors Triplet Regimen in Ovarian Cancer Trial
December 1st 2016A multipronged attack on the tumor vasculature network is at the heart of a recently launched clinical trial aimed at developing new therapeutic options for women with advanced, recurrent, platinum-resistant ovarian cancer.
IDO Inhibitors Among Immunotherapy Strategies Under Study in Glioblastoma
November 30th 2016The concept of using immunotherapies to treat patients with glioblastoma multiforme is gaining ground among researchers who are interested not only in evaluating checkpoint blockade agents that have proved effective in other tumor types but also in exploring novel targets.